These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6417774)

  • 1. Myocardial preservation during anoxic arrest. Chemical cardioplegia.
    Vejlsted H; Andersen K; Husum B; Fischer Hansen B; Arnbjerg J
    Scand J Thorac Cardiovasc Surg; 1983; 17(3):265-8. PubMed ID: 6417774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of multidose cardioplegia and hypothermia in myocardial preservation during ischemic arrest.
    Engelman RM; Auvil J; O'Donoghue MJ; Levitsky S
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):555-63. PubMed ID: 642549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery.
    Beyersdorf F; Krause E; Sarai K; Sieber B; Deutschländer N; Zimmer G; Mainka L; Probst S; Zegelman M; Schneider W
    Thorac Cardiovasc Surg; 1990 Feb; 38(1):20-9. PubMed ID: 2106735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of cardioplegic solution without potassium: experimental study in rat.
    Reichert K; Carmo HR; Lima F; Torina AG; Vilarinho KA; Oliveira PP; Silveira Filho LM; Severino ES; Petrucci O
    Rev Bras Cir Cardiovasc; 2013; 28(4):524-30. PubMed ID: 24598959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia.
    Ebel D; Preckel B; You A; Müllenheim J; Schlack W; Thämer V
    Br J Anaesth; 2002 Jun; 88(6):828-35. PubMed ID: 12173202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation.
    Lima ML; Fiorelli AI; Vassallo DV; Pinheiro BB; Stolf NA; Gomes OM
    Rev Bras Cir Cardiovasc; 2012; 27(1):110-6. PubMed ID: 22729308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nitric oxide donor, S-nitroso human serum albumin, as an adjunct to HTK-N cardioplegia improves protection during cardioplegic arrest after myocardial infarction in rats.
    Trescher K; Dzilic E; Kreibich M; Gasser H; Aumayr K; Kerjaschki D; Pelzmann B; Hallström S; Podesser BK
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):387-94. PubMed ID: 25468794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of small-amplitude electrical activity on myocardial preservation in the cold potassium-arrested heart.
    Landymore RW; Marble AE; Trillo A; MacAulay M; Faulkner G; Cameron C
    J Thorac Cardiovasc Surg; 1986 May; 91(5):684-9. PubMed ID: 3702477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood flow during early cardiopulmonary bypass in man. Effect of procaine in cardioplegic solutions.
    Henriksen L; Barry DI; Rygg IH; Skovsted P
    Thorac Cardiovasc Surg; 1986 Apr; 34(2):116-23. PubMed ID: 2424126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates.
    Jynge P; Hearse DJ; Braimbridge MV
    J Thorac Cardiovasc Surg; 1977 Jun; 73(6):848-55. PubMed ID: 859352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Cardioplegia on the contractile apparatus level": evaluation of a new concept for myocardial preservation in perfused pig hearts.
    Vahl CF; Bonz A; Hagl C; Timek T; Herold U; Fuchs H; Kochsiek N; Hagl S
    Thorac Cardiovasc Surg; 1995 Aug; 43(4):185-93. PubMed ID: 7502280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney function parameters following ischemia stress using the Euro-Collins solution or the Bretschneider cardioplegic HTK solution].
    Kallerhoff M; Blech M; Kehrer G; Kleinert H; Langheinrich M; Siekmann W; Helmchen U; Bretschneider HJ
    Urologe A; 1987 Mar; 26(2):96-103. PubMed ID: 3109096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial pH during elective arrest of the heart: relative effects of hypothermia versus potassium cardioplegia on anaerobic metabolism.
    Wilson GJ; Robertson JM; Walters FJ; Steward DJ; MacGregor DC
    Ann Thorac Surg; 1980 Nov; 30(5):472-81. PubMed ID: 7436618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Custodial-HTK Solution for Myocardial Protection in CABG Patients.
    Prathanee S; Kuptanond C; Intanoo W; Wongbhudha C; Karunasumaeta C
    J Med Assoc Thai; 2015 Aug; 98 Suppl 7():S164-7. PubMed ID: 26742385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cross-clamp time, temperature, and cardioplegic agents on myocardial function after induced arrest.
    Kay HR; Levine FH; Fallon JT; Grötte GJ; Butchart EG; Rao S; McEnany MT; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1978 Nov; 76(5):590-603. PubMed ID: 703364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of procaine-induced cardioplegia on myocardial ischemia, myocardial edema, and postarrest ventricular function. A comparison with potassium-induced cardioplegia and hypothermia.
    Bixler TJ; Gardner TJ; Flaherty JT; Goldman RA; Gott VL
    J Thorac Cardiovasc Surg; 1978 Jun; 75(6):886-93. PubMed ID: 661357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the solutions of Bretschneider, St. Thomas' Hospital and the National Institutes of Health for cardioplegic protection during moderate hypothermic arrest.
    Kober IM; Obermayr RP; Brüll T; Ehsani N; Schneider B; Spieckermann PG
    Eur Surg Res; 1998; 30(4):243-51. PubMed ID: 9704750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioplegic solutions for myocardial preservation: analysis of hypothermic arrest, potassium arrest, and procaine arrest.
    Harlan BJ; Ross D; Macmanus Q; Knight R; Luber J; Starr A
    Circulation; 1978 Sep; 58(3 Pt 2):I114-8. PubMed ID: 14740690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative buffering power of cardioplegic solutions.
    Kresh JY; Nastala C; Bianchi PC; Goldman SM; Brockman SK
    J Thorac Cardiovasc Surg; 1987 Feb; 93(2):309-11. PubMed ID: 3100872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histidine-Tryptophan-Ketoglutarate Solution versus Blood Cardioplegia in Cardiac Surgery: A Propensity-Score Matched Analysis.
    Pizano A; Montes FR; Carreño M; Echeverri D; Umaña JP
    Heart Surg Forum; 2018 May; 21(3):E158-E164. PubMed ID: 29893672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.